Cargando…
Inducing CCR5Δ32/Δ32 Homozygotes in the Human Jurkat CD4+ Cell Line and Primary CD4+ Cells by CRISPR-Cas9 Genome-Editing Technology
C-C chemokine receptor type 5 (CCR5) is the main co-receptor for HIV entry into the target CD4+ cells, and homozygous CCR5Δ32/Δ32 cells are resistant to CCR5-tropic HIV infection. However, the CCR5Δ32/Δ32 homozygous donors in populations are rare. Here we developed a simple approach to induce CCR5Δ3...
Autores principales: | Qi, Chunxia, Li, Dan, Jiang, Xiangxiang, Jia, Xiaopeng, Lu, Lingling, Wang, Yanfeng, Sun, Jinhuan, Shao, Yiming, Wei, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005807/ https://www.ncbi.nlm.nih.gov/pubmed/30195765 http://dx.doi.org/10.1016/j.omtn.2018.05.012 |
Ejemplares similares
-
The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005) -
Pleiotropy Complicates Human Gene Editing: CCR5Δ32 and Beyond
por: Li, Ting, et al.
Publicado: (2019) -
Association between the CCR5Δ32 polymorphism and preeclampsia
por: Paula Telini, Bianca de, et al.
Publicado: (2014) -
CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019) -
CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
por: Xu, MengMeng
Publicado: (2020)